Cargando…

Possible Contribution of Taurine to Distorted Glucagon Secretion in Intra-Islet Insulin Deficiency: A Metabolome Analysis Using a Novel α-Cell Model of Insulin-Deficient Diabetes

Glycemic instability is a serious problem in patients with insulin-deficient diabetes, and it may be due in part to abnormal endogenous glucagon secretion. However, the intracellular metabolic mechanism(s) involved in the aberrant glucagon response under the condition of insulin deficiency has not y...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bessho, Megumi, Murase-Mishiba, Yuko, Imagawa, Akihisa, Terasaki, Jungo, Hanafusa, Toshiaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4231115/ https://www.ncbi.nlm.nih.gov/pubmed/25393115 http://dx.doi.org/10.1371/journal.pone.0113254

Ejemplares similares

“Preserved” glucagon secretion in fulminant type 1 diabetes
por: Murase‐Mishiba, Yuko, et al.
Publicado: (2018)

Endogenous insulin secretion even at a very low level contributes to the stability of blood glucose control in fulminant type 1 diabetes
por: Shibasaki, Saeko, et al.
Publicado: (2010)

Antibody to CMRF35-Like Molecule 2, CD300e A Novel Biomarker Detected in Patients with Fulminant Type 1 Diabetes
por: Haseda, Fumitaka, et al.
Publicado: (2016)

Fulminant Type 1 Diabetes as a Model of Nature to Explore the Role of C-Peptide
por: Murase-Mishiba, Yuko, et al.
Publicado: (2008)

Melatonin and Pancreatic Islets: Interrelationships between Melatonin, Insulin and Glucagon
por: Peschke, Elmar, et al.
Publicado: (2013)

Correlation of glycated albumin but not hemoglobin A(1c) with endogenous insulin secretion in fulminant type 1 diabetes mellitus
por: Koga, Masafumi, et al.
Publicado: (2010)

Efficacy of glucagon-like peptide-1 and estrogen dual agonist in pancreatic islets protection and pre-clinical models of insulin-deficient diabetes
por: Fuselier, Taylor, et al.
Publicado: (2022)

“Benifuuki” Extract Reduces Serum Levels of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Ligands Containing Apolipoprotein B: A Double-Blind Placebo-Controlled Randomized Trial
por: Miyawaki, Masahiro, et al.
Publicado: (2018)

Intra-islet glucagon confers β-cell glucose competence for first-phase insulin secretion and favors GLP-1R stimulation by exogenous glucagon
por: Cabrera, Over, et al.
Publicado: (2021)

Glucagon Receptor Knockout Prevents Insulin-Deficient Type 1 Diabetes in Mice
por: Lee, Young, et al.
Publicado: (2011)

Sustained glucagon receptor antagonism in insulin-deficient high-fat-fed mice
por: Lafferty, Ryan A, et al.
Publicado: (2022)

Taking Aim at Islet Hormones With GLP-1: Is Insulin or Glucagon the Better Target?
por: D'Alessio, David A.
Publicado: (2010)

Pathogenesis of fulminant type 1 diabetes: Genes, viruses and the immune mechanism, and usefulness of patient‐derived induced pluripotent stem cells for future research
por: Hosokawa, Yoshiya, et al.
Publicado: (2019)

Intra-islet glucagon secretion and action in the regulation of glucose homeostasis
por: Wang, Qinghua, et al.
Publicado: (2013)

Label-Free Detection of Insulin and Glucagon within Human Islets of Langerhans Using Raman Spectroscopy
por: Hilderink, Janneke, et al.
Publicado: (2013)

Discovery of ciliary G protein-coupled receptors regulating pancreatic islet insulin and glucagon secretion
por: Wu, Chien-Ting, et al.
Publicado: (2021)

Insulin resistance in the liver: Deficiency or excess of insulin?
por: Bazotte, Roberto B, et al.
Publicado: (2014)

Insulin deficiency with and without glucagon: A comparative study between total pancreatectomy and type 1 diabetes
por: Niwano, Fumimaru, et al.
Publicado: (2018)

Oestrogens improve human pancreatic islet transplantation in a mouse model of insulin deficient diabetes
por: Liu, S., et al.
Publicado: (2012)

Mild hyperglycemia triggered islet function recovery in streptozotocin‐induced insulin‐deficient diabetic rats
por: Cheng, Yu, et al.
Publicado: (2016)

Insulin and Glucagon: Partners for Life
por: Holst, Jens Juul, et al.
Publicado: (2017)

Pancreatic Islet-Autonomous Insulin and Smoothened-Mediated Signaling Modulate Identity Changes of Glucagon(+) α-Cells
por: Cigliola, Valentina, et al.
Publicado: (2018)

Pro-Inflammatory Cytokines Induce Insulin and Glucagon Double Positive Human Islet Cells That Are Resistant to Apoptosis
por: Tesi, Marta, et al.
Publicado: (2021)

Differential effects of taurine treatment and taurine deficiency on the outcome of renal ischemia reperfusion injury
por: Mozaffari, Mahmood S, et al.
Publicado: (2010)

β-cell insulin receptor deficiency during in utero development induces an islet compensatory overgrowth response
por: Trinder, Mark, et al.
Publicado: (2016)

Insulin tolerance test predicts the effectiveness of insulin sensitizers in japanese type 2 diabetic patients
por: Kozawa, Junji, et al.
Publicado: (2011)

Small Mouse Islets Are Deficient in Glucagon-Producing Alpha Cells but Rich in Somatostatin-Secreting Delta Cells
por: Lau, Joey, et al.
Publicado: (2016)

Evidence for the existence and potential roles of intra-islet glucagon-like peptide-1
por: Campbell, Scott A., et al.
Publicado: (2021)

Usefulness of the insulin tolerance test in patients with type 2 diabetes receiving insulin therapy
por: Okita, Kohei, et al.
Publicado: (2013)

Insulin-Induced Cardiomyocytes Hypertrophy That Is Prevented by Taurine via β-alanine-Sensitive Na(+)-Taurine Symporter
por: Jazzar, Ashley, et al.
Publicado: (2021)

The Islet Estrogen Receptor-α Is Induced by Hyperglycemia and Protects Against Oxidative Stress-Induced Insulin-Deficient Diabetes
por: Kilic, Gamze, et al.
Publicado: (2014)

Mitochondrial Deficiency Is Associated With Insulin Resistance
por: Goodpaster, Bret H.
Publicado: (2013)

Insulin and glucagon secretions, and morphological change of pancreatic islets in OLETF rats, a model of type 2 diabetes mellitus.
por: Hong, Eun Gyoung, et al.
Publicado: (2002)

Basal hypersecretion of glucagon and insulin from palmitate-exposed human islets depends on FFAR1 but not decreased somatostatin secretion
por: Kristinsson, H., et al.
Publicado: (2017)

In pancreatic islets from type 2 diabetes patients, the dampened circadian oscillators lead to reduced insulin and glucagon exocytosis
por: Petrenko, Volodymyr, et al.
Publicado: (2020)

Impaired Insulin Secretion and Enhanced Insulin Sensitivity in Cholecystokinin-Deficient Mice
por: Lo, Chun-Min, et al.
Publicado: (2011)

Insulin Deficiency From Insulin Gene Mutation Leads to Smaller Pancreas
por: Wright, Jordan J., et al.
Publicado: (2023)

RGS4-Deficiency Alters Intracellular Calcium and PKA-Mediated Control of Insulin Secretion in Glucose-Stimulated Beta Islets
por: Bastin, Guillaume, et al.
Publicado: (2021)

Naringenin and Phytoestrogen 8-Prenylnaringenin Protect against Islet Dysfunction and Inhibit Apoptotic Signaling in Insulin-Deficient Diabetic Mice
por: Park, Song, et al.
Publicado: (2022)

Insulin and Glucagon Impairments in Relation with Islet Cells Morphological Modifications Following Long Term Pancreatic Duct Ligation in the Rabbit – A Model of Non-insulin-dependent Diabete
por: Catala, J., et al.
Publicado: (2001)

Cannot write session to /tmp/vufind_sessions/sess_putniso37j42vp225lutq365jn